Yungjin Pharmaceutical Co., Ltd.
Records under this name other than the patents Yungjin Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 7 of 7 · Back to Yungjin Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,999,646 | Method of Treating Inflammation, Allergy and Asthma with a Purified Extract (ATC1) Isolated from Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount of Active Ingredient Held by another company In force · High confidence | In force | High confidence | |
| US 10,046,019 | Purified Extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma Held by another company In force · High confidence | In force | High confidence | |
| US 10,172,816 | Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 7,009,053 | Quinoline Derivatives as CASPASE-3 Inhibitor, Preparation for Producing the Same and Pharmaceutical Composition Comprising the Same Lapsed on the fee record Ended Mar 7, 2018 · High confidence | Lapsed on the fee record | Ended Mar 7, 2018 | High confidence |
| US 6,043,373 | Heterocycle-fused thiazole derivatives Lapsed on the fee record Ended Mar 28, 2008 · USPTO record | Lapsed on the fee record | Ended Mar 28, 2008 | USPTO record |
| US 5,731,007 | Pharmaceutical composition for skin diseases Term ended Term ended no later than Mar 24, 2018 · Low confidence | Term ended | Term ended no later than Mar 24, 2018 | Low confidence |
| US 5,952,504 | 4-Amino-3-acylnaphthyridine derivatives Term ended Term ended no later than Sep 14, 2019 · Low confidence | Term ended | Term ended no later than Sep 14, 2019 | Low confidence |